News for the Multiple Sclerosis Community

Mercury Fillings Update

The U.S. Food and Drug Administration revised its consumer advice on mercury amalgam fillings in the wake of a settlement in a lawsuit by Moms Against Mercury and other nonprofits against the federal agency.

The FDA Web site now says mercury amalgams "may have neurotoxic effects on the nervous systems of developing children and fetuses." The agency also reopened the comment period until July 28 on a rule designating mercury amalgam as a Class II device with special controls on its use.

Special bonus: the link points to the story being reported in the *Mercury* News :-)